Amarin Corporation plc (AMRN) Stock

Healthcare · Drug Manufacturers - General · Member of Other US Stocks

Amarin Corporation plc (AMRN) closed at USD 11.61 on 2026-10-14, a change of -38.7 % over the past year, with a market capitalization of USD 242.61M.

Amarin Corporation plc recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Amarin Corporation plc key figures

Previous close

USD 11.61 (2026-10-14)

1-year change

-38.7 %

Market cap

USD 242.61M

Enterprise value

USD -63.08M

P/E ratio (trailing)

-9.64

P/E ratio (forward)

11.81

EPS (trailing)

-1.20

EPS (forward)

0.98

PEG ratio

0.81

Price to book

0.55

Revenue growth

-42 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

10.31

Employees

80

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Amarin Corporation plc

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Amarin Corporation plc and compare it with other stocks.